0

Journal Articles

in Drug/Vaccine Safety
 1-20 of 90 Articles
Viewpoint |  May 08, 2013
Investments in Infrastructure for Diverse Research Resources and the Health of the Public
Bruce M. Psaty, MD, PhD; Eric B. Larson, MD, MPH
JAMA. 2013;309(18):1895-1896. doi:10.1001/jama.2013.3445.
Medical News and Perspectives |  May 01, 2013
Judge: No Age Restriction for Emergency Contraceptive
Bridget M. Kuehn, MSJ
JAMA. 2013;309(17):1764. doi:10.1001/jama.2013.4585.
Viewpoint |  April 24, 2013
Stemming the Global Trade in Falsified and Substandard Medicines
Lawrence O. Gostin, JD; Gillian J. Buckley, MPH, PhD; Patrick W. Kelley, MD, DrPH
JAMA. 2013;309(16):1693-1694. doi:10.1001/jama.2013.3048.
Editorial |  April 24, 2013
Risks of In Utero Exposure to Valproate
Kimford J. Meador, MD; David W. Loring, PhD
JAMA. 2013;309(16):1730-1731. doi:10.1001/jama.2013.4001.
Health Agencies Update |  April 24, 2013
Diabetes Drugs Investigated
Bridget M. Kuehn, MSJ
JAMA. 2013;309(16):1674. doi:10.1001/jama.2013.4243.
Medical News and Perspectives |  April 24, 2013
Patients Given Fungus-Tainted Injections Continue to Face Uncertainty, Illness
Bridget M. Kuehn, MSJ
JAMA. 2013;309(16):1669-1670. doi:10.1001/jama.2013.3616.
Original Contribution |  April 24, 2013
Association of Perioperative β-Blockade With Mortality and Cardiovascular Morbidity Following Major Noncardiac Surgery
Martin J. London, MD; Kwan Hur, PhD; Gregory G. Schwartz, MD, PhD; et al.
JAMA. 2013;309(16):1704-1713. doi:10.1001/jama.2013.4135.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  April 24, 2013 FREE
Notes From the Field: Emergency Department Visits and Hospitalizations for Buprenorphine Ingestion by Children—United States, 2010-2011
JAMA. 2013;309(16):1677-1678. doi:10.1001/jama.2013.975.
Viewpoint |  April 03, 2013
Approval of a Tuberculosis Drug Based on a Paradoxical Surrogate Measure
Jerry Avorn, MD
JAMA. 2013;309(13):1349-1350. doi:10.1001/jama.2013.623.
Medical News and Perspectives |  April 03, 2013
IOM: Curbing Fake Drugs Will Require National Tracking and Global Teamwork
Bridget M. Kuehn, MSJ
JAMA. 2013;309(13):1333-1334. doi:10.1001/jama.2013.2376.
JAMA Patient Page |  April 03, 2013 FREE
Statins
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD; Cassio Lynm, MA
JAMA. 2013;309(13):1419. doi:10.1001/jama.2013.3041.
INCLUDES: , Supplemental Content
Editorial |  March 27, 2013
Is Sublingual Immunotherapy Ready for Use in the United States?
Harold S. Nelson, MD
JAMA. 2013;309(12):1297-1298. doi:10.1001/jama.2013.2739.
Medical News and Perspectives |  March 06, 2013
FDA Committee: More Restrictions Needed on Hydrocodone Combination Products
Bridget M. Kuehn, MSJ
JAMA. 2013;309(9):862. doi:10.1001/jama.2013.1609.
Medical News and Perspectives |  March 06, 2013
FDA Warning: New Batch of Fake Bevacizumab Found
Bridget M. Kuehn, MSJ
JAMA. 2013;309(9):864. doi:10.1001/jama.2013.1719.
Viewpoint |  March 06, 2013
Improving Opioid Prescribing:  The New York City Recommendations
David N. Juurlink, MD, PhD; Irfan A. Dhalla, MD, MSc; Lewis S. Nelson, MD
JAMA. 2013;309(9):879-880. doi:10.1001/jama.2013.1139.
Clinical Crossroads |  March 06, 2013
Chronic Back Pain With Possible Prescription Opioid Misuse
Daniel P. Alford, MD, MPH
JAMA. 2013;309(9):919-925. doi:10.1001/jama.2013.522.
INCLUDES: CME
Viewpoint |  March 06, 2013
Responding to the Outbreak of Invasive Fungal Infections:  The Value of Public Health to Americans
Beth P. Bell, MD, MPH; Rima F. Khabbaz, MD
JAMA. 2013;309(9):883-884. doi:10.1001/jama.2013.526.
Editorial |  February 27, 2013
Defining Diastolic Heart Failure and Identifying Effective Therapies
John G. F. Cleland, MD, PhD, FRCP; Pierpaolo Pellicori, MD
JAMA. 2013;309(8):825-826. doi:10.1001/jama.2013.1569.
Caring for the Critically Ill Patient |  February 20, 2013
Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation:  A Systematic Review and Meta-analysis
Ryan Zarychanski, MD, MSc; Ahmed M. Abou-Setta, MD, PhD; Alexis F. Turgeon, MD, MSc; et al.
JAMA. 2013;309(7):678-688. doi:10.1001/jama.2013.430.
INCLUDES: , Supplemental Content
Editorial |  February 20, 2013
Hydroxyethyl Starch for Intravenous Volume Replacement:  More Harm Than Benefit
Massimo Antonelli, MD; Claudio Sandroni, MD
JAMA. 2013;309(7):723-724. doi:10.1001/jama.2013.851.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Dermatology
Research Letters  |  April 01, 2013
Retrospective Review of Adverse Effects From Propranolol in Infants
Eun-Kyung M. Kwon, BA; Shawna Joachim, BA; Dawn H. Siegel, MD; et al.
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  April 01, 2013
Efficacy and Toxicity of Peritumoral Delivery of Nanoconjugated Cisplatin in an In Vivo Murine Model of Head and Neck Squamous Cell Carcinoma
Stephanie M. Cohen, MD, MS; Nick Rockefeller, BS; Ridhwi Mukerji, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems